Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03669289 · ClinicalTrials.gov registry record · NA

Enhanced Support for Behavioral Barriers to Learning: An Evaluation of the SCHOOL STARS Program

A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT03669289: Completed NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT03669289 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03669289, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

This small pilot study will enroll children ages 5-12 years of age with disruptive behavior problems at school. These children and their families will be offered an enhanced model of primary care, which includes pre-visit record review, standardized content of primary care visits, post-visit care coordination by the primary care team, and coordination of services between the primary care team and the school. We hypothesize that children receiving this enhanced model of care will achieve better behavioral outcomes at both school and home.

Primary Outcome

parent-completed assessment of child behavior; T scores for the externalizing subscale range 0-100 with higher scores being worse

Interventions

  • OTHER enhanced model of primary care

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2018-09-14
Est. Completion 2019-04-30
Phase NA

What the finished NCT03669289 record still lists

NCT03669289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which enhanced model of primary care is the first listed.

NCT03669289 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03669289 about?

NCT03669289 is a clinical study titled "Enhanced Support for Behavioral Barriers to Learning: An Evaluation of the SCHOOL STARS Program". This small pilot study will enroll children ages 5-12 years of age with disruptive behavior problems at school. These children and their families will be offered an enhanced model of primary care, which includes pre-visit record review, standardized content of primary care visits, post-visit care co...

What is the current status of trial NCT03669289?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2018-09-14. Estimated completion is 2019-04-30.

What interventions are being tested in trial NCT03669289?

The interventions under investigation include: enhanced model of primary care (OTHER).

Who is sponsoring clinical trial NCT03669289?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03669289's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT03669289, the US trial registry maintained by the National Library of Medicine. NCT03669289 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.